Delayed Recurrence of Mandibular Ameloblastoma in Soft Tissues of Neck: A Case Report of a Rare Entity
Keywords:
Ameloblastoma, Local Neoplasm Recurrence, Odontogenic TumorsAbstract
Ameloblastoma is the second most common odontogenic neoplasm and is locally aggressive. Various treatment approaches exist, with resection involving safe margins associated with the lowest recurrence rates. However, ameloblastoma still has a propensity for delayed recurrences, necessitating lifelong follow-up for patients. Recurrences usually develop at the primary site of the tumor but have also been reported in reconstructive bone grafts. We present a unique case of a very unusual, delayed recurrence of mandibular ameloblastoma in the soft tissues of the neck, 16 years after the primary surgery. The recurrence presented as a large cystic swelling in the neck with a solid component, posing a diagnostic challenge for the team. The final histopathological examination after excision under general anesthesia confirmed it to be ameloblastoma.
Downloads
References
Cadavid AM, Araujo JP, Coutinho-Camillo CM, Bologna S, Junior CA, Lourenco SV. Ameloblastomas: current aspects of the new WHO classification in an analysis of 136 cases. Surg Exp Pathol 2019; 2:1-6. doi:10.1186/s42047-019-0041-z
Neagu D, Escuder-de la Torre O, Vazquez-Mahia I, Carral-Roura N, Rubin-Roger G, Penedo-Vazquez A, et al. Surgical management of ameloblastoma. Review of literature. J Clin Exp Dent 2019; 11:e70-e5. doi:10.4317/jced.55452
Milman T, Ying GS, Pan W, LiVolsi V. Ameloblastoma: 25 Year Experience at a Single Institution. Head Neck Pathol 2016; 10:513-20. doi:10.1007/s12105-016-0734-5
Effiom OA, Ogundana OM, Akinshipo AO, Akintoye SO. Ameloblastoma: current etiopathological concepts and management. Oral Dis 2018; 24:307-16. doi:10.1111/odi.12646
Aramanadka C, Kamath AT, Kudva A. Recurrent Amelob-lastoma: A Surgical Challenge. Case Rep Dent 2018; 8271205. doi:10.1155/2018/8271205
Yang R, Liu Z, Gokavarapu S, Peng C, Ji T, Cao W. Recur-rence and cancerization of ameloblastoma: multivariate analysis of 87 recurrent craniofacial ameloblastoma to assess risk factors associated with early recurrence and secondary ameloblastic carcinoma. Chin J Cancer Res 2017;29:189-95. doi:10.21147/j.issn.1000-9604.2017.03.04
Bi L, Wei D, Hong D, Wang J, Qian K, Wang H, et al. A Retrospective Study of 158 Cases on the Risk Factors for Recurrence in Ameloblastoma. Int J Med Sci 2021; 18:3326- 332. doi:10.7150/ijms.61500
Ajila V, Hegde S. Ameloblastomas vs recurrent amelob-lastomas: A systematic review. J Oral Med Oral Surg. 2022; 28:11. doi:10.1051/mbcb/2021044
Hamdy O, Raafat S, Saleh GA, Awny S, Shebl AM, Hegazy MA. Recurrent mandibular ameloblastoma in soft tissue and rib graft 17 years after initial presentation. J Egypt Natl Canc Inst 2020; 32:1. doi:10.1186/s43046-019-0012-1
McClary AC, West RB, McClary AC, Pollack JR, Fischbein NJ, Holsinger CF, et al. Ameloblastoma: a clinical review and trends in management. Eur Arch Otorhinolaryngol 2016; 273:1649-61. doi:10.1007/s00405-015-3631-8
Adebayo ET, Fomete B, Adekeye EO. Delayed soft tissue recurrence after treatment of ameloblastoma in a black African: case report and review of the literature. J Craniomaxillofac Surg 2011; 39:615-8. doi:10.1016/j.jcms.2010.05.010
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Nabeela Riaz, Samreen Younas
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. 
